27th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress
October 13-16, 2026

Hybrid Onsite Conference & Internet Event — Live and Archived
Washington Hilton
Washington, DC

Follow Pharma Congress on:  


Home

CONGRESS REGISTRATION IS NOW OPEN.

THE 2026 27TH ANNUAL CONGRESS FEATURES:

  • New half-day specialty summits on the afternoon of Tuesday 10/13
  • Over 50 concurrent mini summits and 15 plenary session presentations
  • The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
  • The Industry-only Compliance Best Practices Think Tank hosted by PCF
  • A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
  • Numerous professional networking opportunities


    • FEATURED ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

    Peter Brensilver, JD, MPH

    Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY

    Briana Cabrera, MS, CFE

    Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL

    Regina Cavaliere, JD

    Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein; Former VP, Chief Compliance Officer, Roche Diagnostics, Melville, NY

    Kevin Espinoza, MBA

    Chief Integrity & Compliance Officer, Indivior; Former Chief Integrity & Compliance Officer, Kaleo; Former Senior VP, Boston Scientific, Richmond, VA

    Lindsey LaMoria Gavin

    Senior Director, Deputy Compliance Officer, Lundbeck; Former Compliance Director, Meetings & Events International, Deerfield, IL

    Jeffrey Kawalek, MBA

    Chief Compliance Officer, Zambon US; Former Deputy CCO US, Jazz; Former Co-chair, PCF, New York, NY

    Cheryl Lee, MBA, CHC, CFE

    Head of Compliance, Cycle Pharma; Former VP, ESG Strategy and Execution, Bristol Myers Squibb; Former VP, Head of Compliance Worldwide Markets, Celgene, New York, NY

    Joan Podleski, CCEP, CHPC, CHRC, CHC

    Vice President & Chief Privacy Officer, Children’s Health System of Texas; Former Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX

    Ariadna Quesada, MSJ

    Vice President, Compliance, Global Compliance and Privacy lead, ZOLL Medical; Former Compliance Director, Europe & MEATI, Hillrom; Former Ethics & Compliance Officer, The Netherlands, Abbvie, Madrid, Spain

    R. Brett Short, CHC, CHPC, CHRC

    Chief Compliance Officer & Chief Privacy Officer, University of Kentucky; Immediate Past Chair, Health Care Compliance Association, Lexington, KY

    Ronald Strauss, CIPM

    Vice President Compliance, MiMedx; Former Executive Sales Representative, Eli Lilly Specialty, Marietta, GA

    Betsy Wade, MPH, CHC, CHPC, CAN

    Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY

    Kelly Willenberg, MBA, DBA, CHC, CHRC

    Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC

    Amy Wilson, MBA, MSJ

    Vice President, Chief Compliance Officer, Esperion; Former Head of US Compliance, MorphoSys; Former Director, Enterprise Compliance, Alexion, Boston, MA


    OTHER FEATURED FACULTY

    Eliza L. Andonova, JD

    Partner, Global Regulatory, Hogan Lovells, Washington, DC

    Samantha Barrett Badlam, JD

    Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

    Yogesh Bahl, MBA

    Partner & Practice Leader, Resolution Life Sciences & Healthcare; CFO & Head of Investor Relations, IACTA Pharma, New York, NY

    Craig B. Bleifer, JD

    Partner, McGuire Woods; Former Corporate VP, GC North America; Novo Nordisk; Former SVP, GC & Secretary, Daiichi Sankyo, New York, NY

    Eric Bolesh

    Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

    Jennifer L. Bragg, JD

    Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC

    Jennifer Ceglinski, JD, CFE

    Manager, Forensic & Integrity Services, EY, Charlotte, NC

    Hui Chen, JD

    Co-Founder, Culture. Data. Ethics; Former Compliance Counsel Expert, US DOJ; Former Assistant General Counsel, Pfizer, Honolulu, HI

    Zachary Coseglia, JD

    Co-Founder, Culture. Data. Ethics; Former VP & AGC, Global Compliance Monitoring, Analytics and Digital, Pfizer, Boston, MA

    Layla Covington, JD

    Senior Manager, Compliance Consulting, Cresen; Former Manager, Aggregate Spend, Genentech, Chicago, IL

    Clarissa Crain

    Managing Director, Deloitte, Phoenixville, PA

    Meena Datta, JD

    Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL

    Greg Demske, JD

    Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US HHS, Washington, DC

    Stefanie A. Doebler, JD

    Partner and Co-Chair, Health Care Practice Group, Covington & Burling, Washington, DC

    Kip Ebel, MBA

    Principal, Forensic & Integrity Services, EY, New York, NY

    Ronnie H. Feldman

    Founder, Chief Executive Officer and Creative Director, L&E: Comedians Who Improve Compliance, Chicago, IL

    Sara K. Frank, JD

    Principal, Choate Hall & Stewart, Boston, MA

    Sarah A. Franklin, JD

    Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Former Attorney, US FTC, Washington, DC

    Gary F. Giampetruzzi, JD

    Partner & Global Chair Life Sciences, Paul Hastings; Former VP & AGC, Head of Government Investigations, Pfizer, New York, NY

    Gejaa T. Gobena, JD

    Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

    Neeraj Gupta, MBA

    President, Chief Technology Officer, Cresen Solutions, Chester Springs, PA

    Kris Hall, JD, CIPP/CIPM

    Managing Director, Dovetail; Former VP, Chief Privacy Officer, Celgene; Former VP, Head of Privacy, Shire, Bridgton, ME

    Kristin M. Hicks, JD

    Partner, Arnold & Porter, Washington, DC

    Casey J. Horton, CFE

    Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL

    Erin Brown Jones, MA, JD

    Partner, Latham & Watkins, Washington, DC

    John Kelly, JD

    Partner & Chair, Healthcare Practice, Barnes & Thornburg; Former Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC

    Olivia Krzeminski, JD

    Director of Compliance & Legal Research, G&M Health, Somerset, NJ

    Jeffrey Low, RPh, MHA

    Director, Ankura; Former VP, Clinical Services, Magellan Health; Former Director, Medicare Services, CVS/Caremark, Phoenix, AZ

    Daniel O’Connor

    Senior Vice President, NXLevel Compliance; Angel Investor, Angel Investor Forum, Lambertville, NJ

    Saraswatha Lalitha Putcha

    Director, Product & Client Delivery, Cresen Solutions, Philadelphia, PA

    Nikki Reeves, JD

    Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

    Russell Rose, JD

    Managing Director, Life Sciences Advisory, Deloitte, Dallas, TX

    Paul Silver

    Principal, Life Sciences Regulatory, Legal & Compliance Leader, Deloitte, Atlanta, GA

    L. Stephan Vincze, JD, LLM, MBA

    President & CEO, TRESTLE Compliance; Former SVP & CCO, Warner Chilcot; Former VP & CCO, TAP, Boston, MA

    Robert A. Wells, JD

    Shareholder, Baker Donelson, Baltimore, MD

    Kelly Willenberg, MBA, DBA, CHC, CHRC

    Chief Executive Officer, Kelly Willenberg and Associates, Greenville, SC

    Jane H. Yoon, JD

    Partner, Litigation Department, Paul Hastings; Former Assistant United States Attorney, US Attorney’s Office for the District of New Jersey, New York, NY

    Cobun Zweifel-Keegan, JD, CIPP/US

    Managing Director, International Association of Privacy Professionals; Former Deputy Director, Privacy Initiatives, Better Business Bureau, Washington, DC


    THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

    Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring timely, expert-led deep dives on the hottest issues facing pharma and device companies today. These will include sessions on Advanced Strategies Coordinating Compliance between Medial Affairs and Commercial & Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.


    AN OVERVIEW OF THE 27TH CONGRESS SCHEDULE

    Day 1: Tuesday, October 13,2026

  • Afternoon Half-day Specialty Focused Sessions

    • Day 2: Wednesday, October 14,2026

  • Networking Breakfast

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Opening Plenary Session

  • Networking Reception

    • Day 3: Thursday, October 15,2026

  • Networking Breakfast

  • Morning PCF CCO Roundtable (Invitation-only)

  • Morning Concurrent Mini Summits

  • Networking Luncheon

  • Afternoon Closing Plenary Session

    • Day 4: Friday, October 16,2026

  • Networking Breakfast

  • Morning PCF Industry-only Plenary Session

  • Noon: Congress Adjournment


    • AND REMEMBER THAT ALL ATTENDEES HAVE COMPLIMENTARY ACCESS TO THE CONGRESS VIRTUAL VIDEO ARCHIVE FOR 9 MONTHS FOLLOWING THE EVENT

    FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL

    Featuring one-on-one attendee video chat and large group video interactive workshops.
    See last year’s Congress portal:

    A HYBRID CONFERENCE AND INTERNET EVENT